Donanemab

• Description :

  Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (Aβ) epitope at the N-terminus, showing potential for early Alzheimer's disease research .

• CAS Number :

  1931944-80-7

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Microtubule Associated | Beta Amyloid